Schizophrenia

Children living with parents with mental illness were four times as likely to be placed in out-of-home care than their peers, according to findings from a Swedish study published in Pediatrics.

Long-acting injectable antipsychotic medications reduced hospital readmission rates among patients with schizophrenia and schizoaffective disorder compared with oral antipsychotic medications, according to a recent study.

Wölfflin nodules are light-colored, peripheral iris nodules that are found in 10% of healthy individuals and almost exclusively in patients with light irides.

An investigational, weekly oral dose of risperidone for schizophrenia achieved drug levels comparable to daily Risperdal in a phase 3 study involving Lynx, a long-acting drug delivery platform developed by Lyndra Therapeutics.

The FDA has granted breakthrough device designation for CT-155, an investigational prescription digital therapeutic co-developed by Click Therapeutics and Boehringer Ingelheim to treat negative symptoms of schizophrenia.

Healio’s top atopic dermatitis stories described evidence supporting various treatments, including two reviews of dozens of approaches, as well as physical and mental comorbidities, among other topics.

Bristol Myers Squibb and Karuna Therapeutics Inc. announced a definitive merger agreement that includes Karuna’s lead asset, a muscarinic receptor agonist to treat schizophrenia and Alzheimer’s disease psychosis.

The FDA has cleared for marketing “the world’s first” cloud-based software for clinical analysis of neuromelanin-sensitive MRI scans, according to a press release from the manufacturer.

AbbVie Inc. has acquired Cerevel Therapeutics and its pipeline of clinical stage and preclinical neuroscience candidates in development to address conditions such as Parkinson’s disease, schizophrenia and mood disorders.